11^th European Biosimilars Congress

R Helena Bustos-Cruz studied at the University of Tübingen in Germany and carried out her Postdoctoral studies at the Universidad Nacional in Colombia. She is Group Leader of the Therapeutic Evidence Group at the Universidad de La Sabana. She works in Nanobiosensors development for the evaluation and characterization of molecular interaction in biological drugs. She introduced nanobiosensors (surface plasmon resonance and quartz crystal microbalance) as a new research technology in Colombia. Her group works in the field of safety and efficacy for drugs, clinical pharmacology, and pharmacovigilance. Additionally, she participated in elaborating the evaluation guidelines for biosimilars according to the National Institute for the Monitoring of Medicine and Food (INVIMA).